Related Experiment Videos
Complications of cyclophosphamide therapy
1Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Summary
Cyclophosphamide effectively treats cancers and inflammatory conditions, including those in the head and neck. This review details its pharmacology, toxicities, and management strategies, using Wegener's granulomatosis as a key example.
Area of Science:
- Immunopharmacology
- Oncology
- Rheumatology
Background:
- Cyclophosphamide is a widely used immunosuppressive and cytotoxic agent.
- It is indicated for neoplastic and inflammatory diseases.
- Head and neck manifestations are common in diseases treated with cyclophosphamide.
Purpose of the Study:
- To review the pharmacology of cyclophosphamide.
- To emphasize its toxicities and strategies for minimizing adverse effects.
- To illustrate therapeutic principles using Wegener's granulomatosis.
Main Methods:
- Pharmacological review of cyclophosphamide.
- Discussion of clinical applications and toxicity management.
- Case illustration using Wegener's granulomatosis.
Main Results:
- Cyclophosphamide's mechanism of action and clinical uses are detailed.
- Key toxicities and methods for their mitigation are presented.
- The management of Wegener's granulomatosis highlights cyclophosphamide's therapeutic utility.
Conclusions:
- Cyclophosphamide is a vital therapeutic agent for various conditions.
- Understanding its pharmacology and toxicity is crucial for safe and effective use.
- Wegener's granulomatosis serves as a model for cyclophosphamide therapy in head and neck diseases.